CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...